American Health Intel Rules. Money. Medicine. Decoded daily.
Subscribe
The Ledger · Wednesday, November 18, 2026

The Ledger

Rules. Money. Medicine. Decoded daily.
4 stories · 5 min read
Reading as

CMS wants about $9 billion a year back from Medicare Advantage insurers, and shares of the largest ones fell as the proposal landed. In a CMS fact sheet on the proposed CRUSH rule dated November 16, the Centers for Medicare & Medicaid Services (CMS) proposes to codify three things about risk adjustment data validation (RADV) audits, which check the diagnoses a plan reported against patients’ medical records: no fee-for-service adjuster, CMS sets the sampling method, and extrapolation of audit findings begins with payment year 2018 audits. CMS estimates the approach would collect an average of approximately $9 billion per payment year in Medicare Advantage overpayments. For the whole rule, CMS estimates nearly $90 billion in federal budget savings against about $378.51 million in costs from 2027 to 2036. The rule would also make fraud referrals mandatory for Medicare Advantage and Part D plans, where in 2025 only 46% of contracts voluntarily reported suspected fraud and only 19% reported payment suspensions, and would require every eligible provider billing a Medicare Advantage plan to enroll in Original Medicare, starting the plan year that begins two years after a final rule. Comments are due 60 days after Federal Register publication. Shares of UnitedHealth, Humana and other large Medicare Advantage insurers fell on November 17 and again in morning trading on November 18, per Investing.com, a supplemental source; published declines for UnitedHealth range from about 4% to 5.4% depending on session and outlet, and we did not verify closing prices. The same article quotes a Mizuho analyst calling the added audit scrutiny an incremental negative for Medicare Advantage margins. Who it hits: plans with the largest enrollment, because an extrapolated audit scales a sample error across a whole contract, and their contracted physician groups, which would need Original Medicare enrollment. So what: finance teams at plans and provider groups should read the payment year 2018 start date as a reach into old revenue, and contracting teams should read the enrollment rule as a new credentialing task. Confidence: High on what CMS proposed and its stated estimates; Low on how much would be collected, since this is a proposal and not a final rule.

Star ratings are now a second front: at least 10 Medicare Advantage insurers are suing over their 2027 ratings, with CVS Health putting its exposure at about $2 billion in 2028. The ratings, released October 8, set quality bonus payments for 2028, per Medical Daily’s report, published November 12 and a supplemental source; the court dockets were not reviewed. CVS says lower ratings will cost it about $2 billion in 2028 and that the share of its members in plans rated 4 stars or higher fell from 84% to 67%. Centene says it stands to lose $448 million, and Healthfirst says its drop from 4.5 to 3.5 stars would cost more than $380 million. The suits argue CMS used quality measures it lacked authority to use or did not adopt through proper rulemaking. KFF estimates Medicare will spend at least $13.4 billion on the bonus program in 2026. The article says no court has ruled on a 2027 claim, and that even a recalculation would not change Plan Finder before open enrollment ends December 7. Who it hits: insurers whose 2028 benefit budgets depend on bonus-funded rebates, and members who choose among plans before December 7. So what: insurers now face one federal lever that could claw back old payments and another that has already cut next year’s quality revenue, and both are still moving. Confidence: Med, because the dollar figures are the insurers’ own statements as reported by a trade outlet.

Bertram Capital bought Medical Technology Associates, a Florida firm that tests and certifies the medical gas, lab and calibration systems hospitals depend on. The private equity firm announced the investment November 17 in a Bertram Capital press release, calling it its eighth platform investment in Fund V. Medical Technology Associates, based in Pinellas Park, Florida, has more than 150 technicians and serves hospitals, health systems, pharmacies and laboratories nationwide with testing, inspection, certification, repair and replacement. The seller is Riverarch Equity Partners, which bought the company in 2022. Financing came from Golub Capital and BTG Pactual Strategic Capital. No price was disclosed. Who it hits: hospital facilities and biomedical engineering departments that buy mandatory compliance testing, which now sit with a second private equity owner. So what: this is a low-glamour, recurring-revenue vendor niche, and a sale between two sponsors in three years suggests buyers see steady demand. Confidence: Med to High on the facts, which come from the buyer’s release; our read of the release was partial, so confirm details before relying on them.

LGI Healthcare Solutions agreed to buy QHR Technologies, the maker of Accuro, an electronic medical record the companies say serves about 25,000 providers across Canada. The Montreal-based software company announced the deal November 18 in a LGI Healthcare Solutions press release. The release calls Accuro the largest single-platform electronic medical record in Canada, used by general practitioners, specialists, pharmacists and allied health professionals in community settings. LGI’s CEO called the deal a foundation for international expansion. Terms were not disclosed, and the release does not say whether the deal has closed. Who it hits: Canadian community clinics and pharmacies on Accuro, and rival record vendors. So what: this is a Canadian deal with limited direct effect on U.S. delivery systems, included because it is the largest software transaction we could date inside the last 24 hours. Confidence: Med, since our read of the release was partial and ownership of LGI was not stated.

A note on today’s scan: we checked insurer and hospital-operator filings, rating actions, closures, layoffs, and deal announcements for the last 48 hours. We found no earnings 8-Ks from the large insurers or hospital operators dated today and no health-system rating action we could verify with a date. No new development turned up on Surgery Partners after the November 9 items. Two job-cut reports, Presbyterian Healthcare Services cutting about 135 jobs and athenahealth cutting 4% of staff, surfaced in search results but we could not open the articles, so they are left out. A frontier check of home and ambulatory infusion found one deal we had not reported, below, and nothing else dated this week.

THE DEAL SHEET

TargetAcquirer/InvestorVerticalValueSource
Medical Technology Associates (Pinellas Park, Florida)Bertram Capital (from Riverarch Equity Partners)Healthcare compliance testing and certificationNot disclosed (announced November 17)Bertram Capital release
QHR Technologies (Accuro EMR, Canada)LGI Healthcare SolutionsElectronic medical recordsNot disclosed (announced November 18)LGI release
PromptCare Infusion (home and alternate-site infusion and specialty pharmacy; Waud Capital keeps its respiratory and enteral nutrition unit)AOM InfusionHome and alternate-site infusionNot disclosed (announced November 11, earlier than our window and not previously reported by us)Waud Capital release
Get tomorrow's edition in your inbox.

Free. One email a day at 6pm your time, or one summary every Friday. Switch or stop anytime.

Where these stories are tracked
Get the next issue Free, daily